Perceptive Advisors »

Kestra Med Technologie F shares owned by Perceptive Advisors

Quarter-by-quarter ownership of Kestra Med Technologie F (KMTS) shares owned by Perceptive Advisors from 13F filings

Historical chart of Perceptive Advisors investment in Kestra Med Technologie F

Tip: Access up to 7 years of quarterly data

All positions including Kestra Med Technologie F held by Perceptive Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kestra Med Technologie F by Perceptive Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $7.6M 285k 26.52
2025-03-31 $5.0M 200k 24.92

More positions owned by Perceptive Advisors

Praxis Precision Medicines I Com New (PRAX)
Celcuity (CELC)
Rhythm Pharmaceuticals (RYTM)
Ascendis Pharma A/s Sponsored Adr (ASND)
Apogee Therapeutics (APGE)
Roivant Sciences SHS (ROIV)
Nuvalent Inc-a (NUVL)
Travere Therapeutics (TVTX)
Spdr Series Trust State Street Spd Put Option (XBI)
EXACT Sciences Corporation (EXAS)
Protagonist Therapeutics (PTGX)
Inhibrx Biosciences (INBX)
Edgewise Therapeutics (EWTX)
Immatics SHS (IMTX)
Spyre Therapeutics Com New (SYRE)

View all positions for Perceptive Advisors

Top funds holding Kestra Med Technologie F

Bain Capital Investors
FMR
Yu Fan
Brown Advisory Holdings Incorporated
Alliancebernstein
Omega Fund Management
Vanguard Group
Eventide Asset Management
BlackRock
Franklin Resources
Hood River Capital Management
Federated Investors
Next Century Growth Investors
Driehaus Capital Management
State Street Corporation

View all funds holding Kestra Med Technologie F